{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:49:43Z","timestamp":1789145383824,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In postmenopausal women, lower levels of sex hormone-binding globulin (SHBG) have been linked to various metabolic conditions. The association between SHBG levels and the presence of dyslipidemia was investigated in comparison with other sex hormones.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Data from 570 postmenopausal women were analyzed. To assess the relationship between circulating sex hormone concentrations and dyslipidemia, logistic regression and receiver operating characteristic (ROC) curve analyses were performed to assess the relationships.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Participants had a median age of 51.0 years (49.0\u201353.0). The multivariate analysis revealed that SHBG levels were significantly associated with dyslipidemia. Specifically, low SHBG levels correlated with hypertriglyceridemia and low high-density lipoprotein levels. The area under the curve (AUC) and the optimal SHBG level cutoff value for identifying the presence of dyslipidemia were 0.626 and 69.0 nmol\/L, respectively. The AUCs for SHBG levels were highest for estradiol (E2), total testosterone (TT) and dehydroepiandrosterone sulfate (DHEAS) levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>SHBG levels were significantly associated with dyslipidemia in postmenopausal women and outperformed E2, TT, and DHEAS levels. These findings highlight SHBG as a potential biomarker for dyslipidemia risk in postmenopausal women, warranting further research into its prognostic utility.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12944-025-02634-2","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T10:25:15Z","timestamp":1749551115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association of sex hormone-binding globulin and dyslipidemia with Japanese postmenopausal women: a cross-sectional study"],"prefix":"10.1186","volume":"24","author":[{"given":"Takahiro","family":"Ichikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1707-970X","authenticated-orcid":false,"given":"Hiroshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadao","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiroh","family":"Tanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mako","family":"Nagayoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"2634_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","volume":"18","author":"A Pirillo","year":"2021","unstructured":"Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol. 2021;18:689\u2013700.","journal-title":"Nat Rev Cardiol"},{"key":"2634_CR2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, \u00d4unpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937\u201352.","journal-title":"Lancet"},{"key":"2634_CR3","doi-asserted-by":"publisher","first-page":"E506","DOI":"10.1161\/CIR.0000000000000912","volume":"142","author":"SR El Khoudary","year":"2020","unstructured":"El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, Limacher MC, Manson JE, Stefanick ML, Allison MA. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation. 2020;142:E506\u201332.","journal-title":"Circulation"},{"key":"2634_CR4","first-page":"419","volume":"278","author":"SWJ Lamberts","year":"1997","unstructured":"Lamberts SWJ, van den Beld AW, van der Lely A-J. The endocrinology of aging. Sci (1979). 1997;278:419\u201324.","journal-title":"Sci (1979)"},{"key":"2634_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0026-0495(97)90159-1","volume":"46","author":"R Pasquali","year":"1997","unstructured":"Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O, Labate AMM. Determinants of sex hormone\u2014binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Metabolism. 1997;46:5\u20139.","journal-title":"Metabolism"},{"key":"2634_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0378-5122(95)00969-8","volume":"23","author":"HG Burger","year":"1996","unstructured":"Burger HG. The endocrinology of the menopause. Maturitas. 1996;23:129\u201336.","journal-title":"Maturitas"},{"key":"2634_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s12020-017-1272-y","volume":"56","author":"N Wang","year":"2017","unstructured":"Wang N, Zhang K, Han B, et al. Follicle stimulating hormone, its novel association with sex hormone binding globulin in men and postmenopausal women. Endocrine. 2017;56:649\u201357.","journal-title":"Endocrine"},{"key":"2634_CR8","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1056\/NEJMoa0804381","volume":"361","author":"EL Ding","year":"2009","unstructured":"Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM, Liu S. Sex hormone\u2013binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009;361:1152\u201363.","journal-title":"N Engl J Med"},{"key":"2634_CR9","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1097\/HJH.0000000000003506","volume":"41","author":"MES Watz","year":"2023","unstructured":"Watz MES, Tivesten A, Ottarsdottir K, Li Y, Hellgren MI, Lindblad U, Daka B. Sex hormone-binding globulin levels and development of hypertension in middle-aged men and women. J Hypertens. 2023;41:1565\u201370.","journal-title":"J Hypertens"},{"key":"2634_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/cen.12086","volume":"78","author":"IR Wallace","year":"2013","unstructured":"Wallace IR, McKinley MC, Bell PM, Hunter SJ. Sex hormone binding globulin and insulin resistance. Clin Endocrinol (Oxf). 2013;78:321\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2634_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/0026-0495(92)90271-B","volume":"41","author":"SM Haffner","year":"1992","unstructured":"Haffner SM, Dunn JF, Katz MS. Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women. Metabolism. 1992;41:278\u201384.","journal-title":"Metabolism"},{"key":"2634_CR12","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1161\/01.CIR.0000091114.36254.F3","volume":"108","author":"KM Rexrode","year":"2003","unstructured":"Rexrode KM, Manson JAE, Lee IM, Ridker PM, Sluss PM, Cook NR, Buring JE. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation. 2003;108:1688\u201393.","journal-title":"Circulation"},{"key":"2634_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.0001-6349.2004.00417.x","volume":"83","author":"V Noyan","year":"2004","unstructured":"Noyan V, Yucel A, Sagsoz N. The association of androgenic sex steroids with serum lipid levels in postmenopausal women. Acta Obstet Gynecol Scand. 2004;83:487\u201390.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2634_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5551\/jat1994.8.14","volume":"8","author":"S Kumagai","year":"2001","unstructured":"Kumagai S, Kai Y, Sasaki H. Relationship between insulin resistance, sex hormones and sex hormone-binding globulin in the serum lipid and lipoprotein profiles of Japanese postmenopausal women. J Atheroscler Thromb. 2001;8:14\u201320.","journal-title":"J Atheroscler Thromb"},{"key":"2634_CR15","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1210\/jc.2004-0744","volume":"90","author":"S Mudali","year":"2005","unstructured":"Mudali S, Dobs AS, Ding J, Cauley JA, Szklo M, Golden SH. Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. J Clin Endocrinol Metab. 2005;90:1202\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"2634_CR16","doi-asserted-by":"publisher","first-page":"JE20200147","DOI":"10.2188\/jea.JE20200147","volume":"31","author":"K Takeuchi","year":"2021","unstructured":"Takeuchi K, Naito M, Kawai S, et al. Study profile of the Japan multi-institutional collaborative cohort (J-MICC) study. J Epidemiol. 2021;31:JE20200147.","journal-title":"J Epidemiol"},{"key":"2634_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2188\/jea.JE20100139","volume":"21","author":"K Wakai","year":"2011","unstructured":"Wakai K, Hamajima N, Okada R, et al. Profile of participants and genotype distributions of 108 polymorphisms in a cross-sectional study of associations of genotypes with lifestyle and clinical factors: a project in the Japan Multi-Institutional Collaborative Cohort (J-MICC) study. J Epidemiol. 2011;21:223\u201335.","journal-title":"J Epidemiol"},{"key":"2634_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.maturitas.2011.12.021","volume":"71","author":"H Uemura","year":"2012","unstructured":"Uemura H, Hiyoshi M, Arisawa K, et al. Gene variants in PPARD and PPARGC1A are associated with timing of natural menopause in the general Japanese population. Maturitas. 2012;71:369\u201375.","journal-title":"Maturitas"},{"key":"2634_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-021-00671-y","author":"X Zhang","year":"2021","unstructured":"Zhang X, Liu Y, Li S, et al. Alcohol consumption and risk of cardiovascular disease, cancer and mortality: a prospective cohort study. Nutr J. 2021. https:\/\/doi.org\/10.1186\/s12937-021-00671-y","journal-title":"Nutr J"},{"key":"2634_CR20","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"key":"2634_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2188\/jea.JE20120078","volume":"22","author":"M Hara","year":"2012","unstructured":"Hara M, Higaki Y, Taguchi N, et al. Effect of the PPARG2 Pro12Ala polymorphism and clinical risk factors for diabetes mellitus on HbA1c in the Japanese general population. J Epidemiol. 2012;22:523\u201331.","journal-title":"J Epidemiol"},{"key":"2634_CR22","doi-asserted-by":"crossref","unstructured":"Teramoto T, Sasaki J, Birou S et al. Diagnostic criteria for dyslipidemia executive summary of the Japan Atherosclerosis Society (JAS) Guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan-2012 Version. 2013.","DOI":"10.5551\/jat.15792"},{"key":"2634_CR23","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","volume":"37","author":"BG Nordestgaard","year":"2016","unstructured":"Nordestgaard BG, Langsted A, Mora S, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points - a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37:1944\u201358.","journal-title":"Eur Heart J"},{"key":"2634_CR24","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/CIRCULATIONAHA.114.010001","volume":"130","author":"B Doran","year":"2014","unstructured":"Doran B, Guo Y, Xu J, Weintraub H, Mora S, Maron DJ, Bangalore S. Prognostic value of fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality: insight from the National Health and Nutrition Examination Survey III (NHANES-III). Circulation. 2014;130:546\u201353.","journal-title":"Circulation"},{"key":"2634_CR25","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.jacc.2017.08.006","volume":"70","author":"BG Nordestgaard","year":"2017","unstructured":"Nordestgaard BG. A test in context: lipid profile, fasting versus nonfasting. J Am Coll Cardiol. 2017;70:1637\u201346.","journal-title":"J Am Coll Cardiol"},{"key":"2634_CR26","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, et al. 2020 international society of hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334\u201357.","journal-title":"Hypertension"},{"key":"2634_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13340-020-00439-5","volume":"11","author":"E Araki","year":"2020","unstructured":"Araki E, Goto A, Kondo T, et al. Japanese clinical practice guideline for diabetes 2019. Diabetol Int. 2020;11:165\u2013223.","journal-title":"Diabetol Int"},{"key":"2634_CR28","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"NA ElSayed","year":"2024","unstructured":"ElSayed NA, Aleppo G, Bannuru RR, et al. 2. Diagnosis and classification of diabetes: Standards of care in Diabetes\u20142024. Diabetes Care. 2024;47:S20\u201342.","journal-title":"Diabetes Care"},{"key":"2634_CR29","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1253\/circj.CJ-16-1087","volume":"80","author":"A Goda","year":"2016","unstructured":"Goda A, Masuyama T. Obesity and overweight in Asian people. Circ J. 2016;80:2425\u20136.","journal-title":"Circ J"},{"key":"2634_CR30","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837.","journal-title":"Biometrics"},{"key":"2634_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5527973","author":"C Basualto-Alarc\u00f3n","year":"2021","unstructured":"Basualto-Alarc\u00f3n C, Llanos P, Garc\u00eda-Rivas G, Troncoso MF, Lagos D, Barrientos G, Estrada M. Classic and novel sex hormone binding globulin effects on the cardiovascular system in men. Int J Endocrinol. 2021. https:\/\/doi.org\/10.1155\/2021\/5527973","journal-title":"Int J Endocrinol"},{"key":"2634_CR32","first-page":"1173","volume":"79","author":"G Strain","year":"1994","unstructured":"Strain G, Zumoff B, Rosner W, Pi-Sunyer X. The relationship between serum levels of insulin and sex hormone-binding globulin in men: the effect of weight loss. J Clin Endocrinol Metab. 1994;79:1173\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"2634_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S1056-8727(01)00191-X","volume":"16","author":"S Rashid","year":"2002","unstructured":"Rashid S, Uffelman KD, Lewis GF. The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states. J Diabetes Complications. 2002;16:24\u20138.","journal-title":"J Diabetes Complications"},{"key":"2634_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-018-1101-6","author":"P Bjornstad","year":"2018","unstructured":"Bjornstad P, Eckel RH. Pathogenesis of lipid disorders in insulin resistance: a brief review. Curr Diab Rep. 2018. https:\/\/doi.org\/10.1007\/s11892-018-1101-6","journal-title":"Curr Diab Rep"},{"key":"2634_CR35","doi-asserted-by":"publisher","first-page":"E303","DOI":"10.1210\/clinem\/dgab595","volume":"107","author":"SR El Khoudary","year":"2022","unstructured":"El Khoudary SR, Nasr A, Billheimer J, Brooks MM, McConnell D, Crawford S, Orchard TJ, Rader DJ, Matthews KA. Associations of endogenous hormones with HDL novel metrics across the menopause transition: the SWAN HDL study. J Clin Endocrinol Metab. 2022;107:E303\u201314.","journal-title":"J Clin Endocrinol Metab"},{"key":"2634_CR36","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1161\/01.CIR.0000126889.97626.B8","volume":"109","author":"PP Toth","year":"2004","unstructured":"Toth PP. High-density lipoprotein and cardiovascular risk. Circulation. 2004;109:1809\u201312.","journal-title":"Circulation"},{"key":"2634_CR37","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1001\/jamacardio.2022.0912","volume":"7","author":"C Liu","year":"2022","unstructured":"Liu C, Dhindsa D, Almuwaqqat Z, et al. Association between high-density lipoprotein cholesterol levels and adverse cardiovascular outcomes in high-risk populations. JAMA Cardiol. 2022;7:672.","journal-title":"JAMA Cardiol"},{"key":"2634_CR38","doi-asserted-by":"crossref","unstructured":"Kumagai S, Kai Y, Sasaki H. Relationship between insulin resistance, sex hormones and sex hormone-binding globulin in the serum lipid and lipoprotein profiles of Japanese postmenopausal women. 2001.","DOI":"10.5551\/jat1994.8.14"},{"key":"2634_CR39","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/13697137.2024.2310530","volume":"27","author":"SR Davis","year":"2024","unstructured":"Davis SR, Azene ZN, Tonkin AM, Woods RL, McNeil JJ, Islam RM. Higher testosterone is associated with higher HDL-cholesterol and lower triglyceride concentrations in older women: an observational study. Climacteric. 2024;27:282\u20138.","journal-title":"Climacteric"},{"key":"2634_CR40","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/gme.0b013e3181559860","volume":"15","author":"G Joon Cho","year":"2008","unstructured":"Joon Cho G, Hyun Lee J, Tae Park H, Ho Shin J, Cheol Hong S, Kim T, Young Hur J, Wan Lee K, Kyun Park Y, Haeng Kim S. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause. 2008;15:524\u20139.","journal-title":"Menopause"},{"key":"2634_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1210\/rp.57.1.257","volume":"57","author":"HG Burger","year":"2002","unstructured":"Burger HG. Hormonal changes in the menopause transition. Recent Prog Horm Res. 2002;57:257\u201375.","journal-title":"Recent Prog Horm Res"},{"key":"2634_CR42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1210\/jcem-64-3-513","volume":"64","author":"C LONGCOPE","year":"1987","unstructured":"Longcope C, Hui SL, Johnston CC. Free estradiol, free testosterone, and sex hormone-binding globulin in perimenopausal women**. J Clin Endocrinol Metab. 1987;64:513\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2634_CR43","first-page":"47","volume":"23","author":"SL Wong","year":"2012","unstructured":"Wong SL, Shields M, Leatherdale S, Malaison E, Hammond D. Assessment of validity of self-reported smoking status. Health Rep. 2012;23:47\u201353.","journal-title":"Health Rep"},{"key":"2634_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1359-6357.2003.00586.x","volume":"98","author":"FK Del Boca","year":"2003","unstructured":"Del Boca FK, Darkes J. The validity of self-reports of alcohol consumption: state of the science and challenges for research. Addiction. 2003;98:1\u201312.","journal-title":"Addiction"},{"key":"2634_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pcad.2022.11.003","volume":"75","author":"A Agarwala","year":"2022","unstructured":"Agarwala A, Petersen KS, Jafari F, Kris-Etherton PM. Dietary management of dyslipidemia and the impact of dietary patterns on lipid disorders. Prog Cardiovasc Dis. 2022;75:49\u201358.","journal-title":"Prog Cardiovasc Dis"},{"key":"2634_CR46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/10507250252949405","volume":"12","author":"LH Duntas","year":"2002","unstructured":"Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12:287\u201393.","journal-title":"Thyroid"},{"key":"2634_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1677\/JME-09-0025","volume":"43","author":"DM Selva","year":"2009","unstructured":"Selva DM, Hammond GL. Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4\u03b1. J Mol Endocrinol. 2009;43:19\u201327.","journal-title":"J Mol Endocrinol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02634-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02634-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02634-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T16:03:36Z","timestamp":1749571416000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02634-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2634"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02634-2","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Institutional Ethics Committee of the Kyoto Prefectural University of Medicine (approval number: ERB-C-3202 at 2024) and was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}